Prognostic significance of serum uric acid in patients admitted to the department of medicine

American Journal of the Medical Sciences

Volumn 339, Issue 1, 2010, Pages 15-21

  Wasserman, Asaf ^a,b   Shnell, Matti ^a,b   Boursi, Ben ^a,b   Guzner Gur, Hanan ^a,b  

^a Tel Aviv Souraski Medical Center   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Biomarker; Prognosis; Internal Medicine; Mortality; Uric acid

Indexed keywords

C REACTIVE PROTEIN; DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL STUDY; COMORBIDITY; EPIDEMIOLOGICAL DATA; FEMALE; GENDER; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; INFECTION; INFLAMMATION; INTERNAL MEDICINE; LABORATORY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROGNOSIS; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL;

EID: 75449116339     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181bbb647     Document Type: Article

References (33)

1. Shy Y, Evans JE, Rock KL. Molecular identification of a danger signal that stress the immune system to dying cells. Nature 2003;425: 516-521
2. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenases-2. Hypertension 2003;41:1287-1293
3. Bagnati M, Perugini C, Cau C, et al. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 1999;340: 143-152
4. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle proliferation by increasing platelets derived growth factor A chain expression. J Biol Chem 1991;266:8604-8608
5. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739-1742
6. Corry BD, Tuck ML. Uric acid and the vasculature. Curr Hypertens Res 2006;8:116-119
7. Patetsios P, Rodino W, Wisswlink W, et al. Identification of uric acid in aortic aneurysm and atherosclerotic artery. Ann NY Acad Sci 1996;800:243-245
8. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality; the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2003;283:2404-2410
9. Liese AD, Hense HW, Lowel H, et al. Association of serum uric acid with all cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort; WHO Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999;10:391-397
10. Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 2000;36:1072-1078
11. Wang JG, Staessen JA, Fagard RH, et al. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 2001;36:1069-1074
12. Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000;18:1149-1154 (Pubitemid 30680326)
13. Niskanen LK, Laaksonen DE, Nyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004;164:1546-1551
14. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004;555:589-606.
15. Kittleson MM, St. John ME, Bead V, et al. Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels. Heart 2007;93:365-367
16. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic function, and hemodynamic staging. Circulation 2003;107:1991-1997
17. Nakagawa T, Cirrilo P, Sato W, et al. The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern Emerg Med 2008;3:313-318
18. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997;51:1908-1919
19. Iseki K, Oshoro S, Tozawa M, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001;24:691-697
20. Black HR, Davis B, Barzilay J, et al; Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high risk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretics: the hypertensive, lipid lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002;288:2981-2997
21. Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and morality in patients randomized to double-blind treatment with a long-acting calcium- channel blocker or diuretic in the International Nifedipine GITS Study: intervention as a goal in hypertension treatment (INSIGHT). Lancet 2000;356:366-372
22. Hoieggen A, Alderman MH, Kjeldsen SE, et al. The impact of serum uric acid on cardiovascular outcome in the LIFE study. Kidney Int 2004;65:1041-1049
23. Milionis HJ, Kakafika AI, Tsouli SG, et al. Effect of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J 2004;148:635-640
24. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358: 2148-2159
25. Ioachimescu A, Brennan D, Hoar B, et al. Serum uric acid is an independent predictor of all cause mortality in patients at high risk of cardiovascular disease. Arthritis Rheum 2008;58:623-630
26. Levy WC, Mozzaffarian D, Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation 2006;113:1424-1433
27. Feig D, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359:1811-1821
28. Keshet R, Boursi B, Maoz R, et al. Diagnostic and prognostic significance of serum CRP levels in patients admitted to the department of medicine. Am J Med Sci 2009;337:248-255
29. Hare JM, Mangal B, Brown J, et al. Impact of oxypurinol in patients with symptomatic heart failure: results of the OPT-CHF study. J Am Coll Cardiol 2008;51:2301-2309
30. Tsukimori K, Yoshitomi T, Morkuma S, et al. Serum uric acid levels in preeclampsia. Am J Hypertens 2008;21:1343-1346
31. George J, Carr E, Davies J, et al. High-dose allopurinol improves endothelial dysfunction by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006;114:2508-2516
32. Waring WS, McKnight JA, Webb DJ, et al. Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 2006;55:3127-3132
33. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305